Family Office Of America (FOFA) Net Equity Issued and Repurchased (2021 - 2025)
Family Office Of America (FOFA) reported Net Equity Issued and Repurchased of $50000.0 for Q4 2025, down 80.77% sequentially from $260000.0 in Q3 2025.
Family Office Of America (FOFA) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends
Family Office Of America (FOFA) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $50000.0 in Q4 2025.
- For the quarter ending Q4 2025, Net Equity Issued and Repurchased changed N/A year-over-year to $50000.0; the trailing twelve-month figure through Dec 2025 stood at $965000.0 (up 865.0% YoY), and the FY2025 full-year result was $965000.0, up 865.0% from the prior year.
- Net Equity Issued and Repurchased fell to $50000.0 in Q4 2025, from $260000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $575000.0 in Q1 2025 to a low of -$100000.0 in Q3 2021.
- A 3-year average of $160833.3 and a median of $90000.0 in 2024 frame the typical range for Net Equity Issued and Repurchased.
- Peak annual rise in Net Equity Issued and Repurchased reached 475.0% in 2025, while the deepest fall reached 475.0% in 2025.
- Tracing FOFA's Net Equity Issued and Repurchased over 3 years: stood at -$100000.0 in 2021, then surged by 200.0% to $100000.0 in 2024, then tumbled by 50.0% to $50000.0 in 2025.
- Business Quant data shows FOFA's Net Equity Issued and Repurchased at $50000.0 in Q4 2025, $260000.0 in Q3 2025, and $80000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Family Office Of America | 27.22 Mn | 26.88 Mn | 783,126.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 50,000.00 |
| Dec 31, 2025 | 50,000.00 |
| Sep 30, 2025 | 260,000.00 |
| Sep 30, 2025 | 260,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Jun 30, 2025 | 80,000.00 |
| Mar 31, 2025 | 575,000.00 |
| Mar 31, 2025 | 575,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Sep 30, 2021 | -100,000.00 |
| Sep 30, 2021 | -100,000.00 |